Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah Fraser

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
BMC Infectious Diseases|July 10, 2023
Estimating hepatitis B virus prevalence among key population groups for European Union and European Economic Area countries and the United Kingdom: a modelling studyAdam Trickey, Sandra Bivegete, Erika Duffell, et al.
The Journal of Infectious Diseases|July 25, 2024
Testing and Treatment Interventions in Community Settings Key to Controlling a Recent Human Immunodeficiency Virus Outbreak Among People Who Inject Drugs in Glasgow: A Modeling StudyLara I Allen, Hannah Fraser, Jack Stone, et al.
Nature Ecology & Evolution|May 24, 2018
Empowering peer reviewers with a checklist to improve transparencyTimothy H Parker, Simon C Griffith, Judith L Bronstein, et al.
Health Technology Assessment (Winchester, England)|September 16, 2017
Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluationG J Melendez-Torres, Peter Auguste, Xavier Armoiry, et al.
AIDS and Behavior|July 3, 2021
Overlapping Key Populations and HIV Transmission in Tijuana, Mexico: A Modelling Analysis of Epidemic DriversHannah Fraser, Annick Borquez, Jack Stone, et al.
The International Journal on Drug Policy|May 30, 2026
Can real-world scaling up HCV treatment in people who inject drugs be cost-saving: an economic modelling study in the UKZoe Ward, Hannah Fraser, Stuart Mc Pherson, et al.
Journal of Viral Hepatitis|August 9, 2019
Modelling the potential prevention benefits of a treat-all hepatitis C treatment strategy at global, regional and country levels: A modelling studyAdam Trickey, Hannah Fraser, Aaron G Lim, et al.
BMJ Open|December 1, 2021
Factors associated with attendance at screening for breast cancer: a systematic review and meta-analysisRebecca Mottram, Wendy Lynn Knerr, Daniel Gallacher, et al.
The International Journal on Drug Policy|October 6, 2022
Interventions to prevent HIV and Hepatitis C among people who inject drugs: Latest evidence of effectiveness from a systematic review (2011 to 2020)Norah Palmateer, Victoria Hamill, Anne Bergenstrom, et al.
The Lancet. Gastroenterology & Hepatology|April 15, 2019
The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling studyAdam Trickey, Hannah Fraser, Aaron G Lim, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
BMC Infectious Diseases|July 10, 2023
Estimating hepatitis B virus prevalence among key population groups for European Union and European Economic Area countries and the United Kingdom: a modelling studyAdam Trickey, Sandra Bivegete, Erika Duffell, et al.
The Journal of Infectious Diseases|July 25, 2024
Testing and Treatment Interventions in Community Settings Key to Controlling a Recent Human Immunodeficiency Virus Outbreak Among People Who Inject Drugs in Glasgow: A Modeling StudyLara I Allen, Hannah Fraser, Jack Stone, et al.
Nature Ecology & Evolution|May 24, 2018
Empowering peer reviewers with a checklist to improve transparencyTimothy H Parker, Simon C Griffith, Judith L Bronstein, et al.
Health Technology Assessment (Winchester, England)|September 16, 2017
Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluationG J Melendez-Torres, Peter Auguste, Xavier Armoiry, et al.
AIDS and Behavior|July 3, 2021
Overlapping Key Populations and HIV Transmission in Tijuana, Mexico: A Modelling Analysis of Epidemic DriversHannah Fraser, Annick Borquez, Jack Stone, et al.
The International Journal on Drug Policy|May 30, 2026
Can real-world scaling up HCV treatment in people who inject drugs be cost-saving: an economic modelling study in the UKZoe Ward, Hannah Fraser, Stuart Mc Pherson, et al.
Journal of Viral Hepatitis|August 9, 2019
Modelling the potential prevention benefits of a treat-all hepatitis C treatment strategy at global, regional and country levels: A modelling studyAdam Trickey, Hannah Fraser, Aaron G Lim, et al.
BMJ Open|December 1, 2021
Factors associated with attendance at screening for breast cancer: a systematic review and meta-analysisRebecca Mottram, Wendy Lynn Knerr, Daniel Gallacher, et al.
The International Journal on Drug Policy|October 6, 2022
Interventions to prevent HIV and Hepatitis C among people who inject drugs: Latest evidence of effectiveness from a systematic review (2011 to 2020)Norah Palmateer, Victoria Hamill, Anne Bergenstrom, et al.
The Lancet. Gastroenterology & Hepatology|April 15, 2019
The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling studyAdam Trickey, Hannah Fraser, Aaron G Lim, et al.
Pageof 9